TITLE

Quebec's $100-million campaign targets meningococcal disease

AUTHOR(S)
Pinker, Susan
PUB. DATE
November 2001
SOURCE
CMAJ: Canadian Medical Association Journal;11/27/2001, Vol. 165 Issue 11, p1520
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports on a mass vaccination program in Quebec against meningococcal disease. How two outbreaks of the disease within ten years prompted the vaccination program; Development of a vaccine by Merck Frosst which was fast-tracked through the approval process in Canada; Public support for the campaign.
ACCESSION #
5545203

 

Related Articles

  • Meningococcal disease, Burkina Faso - update.  // Weekly Epidemiological Record;4/27/2007, Vol. 82 Issue 17, p141 

    The provides updates on the reported Meningococcal disease epidemic in Burikina Faso from January 1 to April 2007. According to the Ministry of Health of Burkina Faso, there are 22, 255 suspected cases. They added that 34 districts are over the epidemic threshold were cerebrospinal fluid...

  • Méningococcie, Burkina Faso - mise à jour.  // Weekly Epidemiological Record;4/27/2007, Vol. 82 Issue 17, p141 

    The provides updates on the reported Meningococcal disease epidemic in Burikina Faso from January 1 to April 2007. According to the Ministry of Health of Burkina Faso, there are 22, 255 suspected cases. They added that 34 districts are over the epidemic threshold were cerebrospinal fluid...

  • Prolonged University Outbreak of Meningococcal Disease Associated With a Serogroup B Strain Rarely Seen in the United States. Mandal, Sema; Wu, Henry M.; MacNeil, Jessica R.; Machesky, Kimberly; Garcia, Jocelyn; Plikaytis, Brian D.; Quinn, Kim; King, Larry; Schmink, Susanna E.; Wang, Xin; Mayer, Leonard W.; Clark, Thomas A.; Gaskell, James R.; Messonnier, Nancy E.; DiOrio, Mary; Cohn, Amanda C. // Clinical Infectious Diseases;Aug2013, Vol. 57 Issue 3, p344 

    In 2008–2010, 13 cases, including 1 death, were reported from a university outbreak of meningococcal disease, attributable to a novel serogroup B strain (clonal complex ST-269) in the United States. Risk factors associated with disease were indicative of increased social...

  • Meningococcal Polysaccharide Vaccines.  // Clinical Pediatrics;Sep1977, Vol. 16 Issue 9, p764 

    Presents the recommendations of the Public Health Service Advisory Committee on immunization practices. Overview of meningococcal disease; Types of meningococcal polysaccharide vaccines; Epidemic control; Contraindications.

  • Public management of an outbreak of group C meningococcal disease in university campus residents. Round, Alison; Evans, Meirion R.; Salmon, Roland L.; Hosein, Ian K.; Mukerjee, Arun K.; Smith, R. William J.; Palmer, Stephen R. // European Journal of Public Health;Dec2001, Vol. 11 Issue 4, p431 

    Focuses on a study on public health management of an outbreak of group C meningococcal disease in university campus residents. Outbreak description and investigation; Clinical and diagnostic characteristics of cases; Risk factors for carriage of Neisseria meningitidis.

  • Clonal Waves of Neisseria Colonisation and Disease in the African Meningitis Belt: Eight-Year Longitudinal Study in Northern Ghana. Leimkugel, Julia; Hodgson, Abraham; Forgor, Abudulai Adams; Pflüger, Valentin; Dangy, Jean-Pierre; Smith, Tom; Achtman, Mark; Gagneux, Sébastien; Pluschke, Gerd // PLoS Medicine;Mar2007, Vol. 4 Issue 3, p0535 

    Background The Kassena-Nankana District of northern Ghana lies in the African "meningitis belt" where epidemics of meningococcal meningitis have been reoccurring every eight to 12 years for the last 100 years. The dynamics of meningococcal colonisation and disease are incompletely understood,...

  • Meningococcal serogroup B outbreaks and use of 4CMenB vaccine. Rose, Warren E. // Journal of the American Pharmacists Association: JAPhA;Mar/Apr2014, Vol. 54 Issue 2, p198 

    The article reports on the use of 4CMenB vaccine to prevent meningococcal serogroup B outbreaks in the U.S. It discusses issues related to the recommended dosing schedule of 4CMenB and the important role played by pharmacists in routine immunization for the disease. A chart is also presented...

  • Meningococcal disease, Kenya.  // Weekly Epidemiological Record;3/10/2006, Vol. 81 Issue 10, p89 

    The article reports on the total number of Meningococcal disease in Kenya. The International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control has provided trivalent vaccines, chloramphenicol, rapid tests, and transport media for the affected areas.

  • Vaccine to curb meningococcal epidemic.  // New Zealand Science Teacher;2004, Issue 106, p4 

    Reports on a project to develop and test a vaccine against the Meningococcus strain that is causing most of the disease in New Zealand. Diseases caused by Neisseria meningitidis; Known strains of Meningococcus; Selection of a surface protein to develop a vaccine.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics